SARS-CoV-2 and hepatitis

Authors

  • Marco Trevenzoli Department of Medicine, Infectious Diseases Unit, Azienda Ospedale Università di Padova, Padova, Italy
  • Aurelio Guarnaccia Department of Medicine, Infectious Diseases Unit, Azienda Ospedale Università di Padova, Padova, Italy
  • Irene Alberici Department of Medicine, Infectious Diseases Unit, Azienda Ospedale Università di Padova, Padova, Italy
  • Matteo Fassan Department of Surgery, Oncology and Gastroenterology, Azienda Ospedale Università di Padova, Padova, Italy
  • Eugenia Di Meco Department of Medicine, Infectious Diseases Unit, Azienda Ospedale Università di Padova, Padova, Italy
  • Fabio Farinati Department of Surgery, Oncology and Gastroenterology, Azienda Ospedale Università di Padova, Padova, Italy
  • Anna Maria Cattelan Department of Medicine, Infectious Diseases Unit, Azienda Ospedale Università di Padova, Padova, Italy

DOI:

https://doi.org/10.15403/jgld-2747

Keywords:

Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV-2, COVID-19, Coronavirus infection, Hepatis viral

Abstract

.

Downloads

Published

2020-09-09

How to Cite

1.
Trevenzoli M, Guarnaccia A, Alberici I, Fassan M, Di Meco E, Farinati F, Cattelan AM. SARS-CoV-2 and hepatitis. JGLD [Internet]. 2020 Sep. 9 [cited 2026 Jul. 14];29(3):473-5. Available from: https://www.jgld.ro/jgld/index.php/jgld/article/view/2747

Issue

Vol. 29 No. 3: September 2020

Section

Letters